Ignite Creation Date:
2024-07-17 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06489730
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-06-28
Brief Title:
HAPH Registry Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
HAPH Registry Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the current study is to evaluate the clinical and physiologic course of Kyrgyz highlanders with high altitude pulmonary hypertension HAPH by performing a longitudinal cohort study To this end the investigators will invite the same highlanders who participate din the study in 2017 to undergo follow-up examinations in 2024 in order to allow comparisons of current results with baseline data from 2017
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None